AMICUS THERAPEUTICS Earnings Results: $FOLD Reports Quarterly Earnings

AMICUS THERAPEUTICS ($FOLD) posted quarterly earnings results on Wednesday, February 19th. The company reported earnings of $0.09 per share, beating estimates of $0.01 by $0.08. The company also reported revenue of $149,710,000, missing estimates of $150,972,546 by $-1,262,546.

You can see Quiver Quantitative's $FOLD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

AMICUS THERAPEUTICS Insider Trading Activity

AMICUS THERAPEUTICS insiders have traded $FOLD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $FOLD stock by insiders over the last 6 months:

• BRADLEY L CAMPBELL (President and CEO) has made 0 purchases and 5 sales selling 37,901 shares for an estimated $427,175.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AMICUS THERAPEUTICS Hedge Fund Activity

We have seen 133 institutional investors add shares of AMICUS THERAPEUTICS stock to their portfolio, and 162 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO removed 5,705,679 shares (-44.2%) from their portfolio in Q4 2024, for an estimated $53,747,496
• CITADEL ADVISORS LLC added 4,609,786 shares (+127.0%) to their portfolio in Q4 2024, for an estimated $43,424,184
• WELLINGTON MANAGEMENT GROUP LLP added 4,497,950 shares (+18.8%) to their portfolio in Q4 2024, for an estimated $42,370,689
• PERCEPTIVE ADVISORS LLC removed 3,811,504 shares (-13.6%) from their portfolio in Q4 2024, for an estimated $35,904,367
• VESTAL POINT CAPITAL, LP added 3,350,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $31,557,000
• JANUS HENDERSON GROUP PLC removed 2,940,177 shares (-46.4%) from their portfolio in Q4 2024, for an estimated $27,696,467
• MORGAN STANLEY removed 2,093,663 shares (-49.7%) from their portfolio in Q4 2024, for an estimated $19,722,305

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AMICUS THERAPEUTICS Government Contracts

We have seen $1,474,414 of award payments to $FOLD over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

• GALAFOLD: $261,090
• GALIFOLD 123MG: $197,020
• ::GALAFOLD (MIGALASTAT) 123 MG CAPSULES::: $147,626
• GALAFOLD (MIGALASTAT): $84,357
• GALAFOLD (MIGALASTAT) 123MG CAPS: $65,673

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.